Author:
Ben Abid F.,Gazzah A.,Ousbane A.,Gutierrez M.,Brain E.
Publisher
Computers, Materials and Continua (Tech Science Press)
Reference63 articles.
1. Antman KH, Ryan L, Elias A, et al. (1989) Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol 7(1): 126–31
2. Bailey HH, Ripple G, Tutsch KD, et al. (1997) Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous mephalan. J Natl Cancer Inst 89(23): 1789–96
3. Bergsagel DE, Sprague CC, Austin C, Griffith KM (1962) Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806). Cancer Chemother Rep 21: 87–99
4. Boddy AV, Cole M, Pearson AD, Idle JR (1995) The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion. Cancer Chemother Pharmacol 36(1): 53–60
5. Boddy AV, English M, Pearson AD, et al. (1996) Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics. Eur J Cancer 32A(7): 1179–84
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献